Dorsey Wright & Associates Aldeyra Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$5.77 - $9.93 $2,059 - $3,545	-357 Reduced 9.97%	3,223 $32,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $18,186 - $25,382	3,580 New	3,580 $24,000
Q4 2020 Jan 28, 2021	SELL	$6.31 - $8.13 $7,786 - $10,032	-1,234 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$4.0 - $7.53 $4,936 - $9,292	1,234 New	1,234 $9,000
Q2 2019 Jul 02, 2019	SELL	$6.0 - $9.0 $4,800 - $7,200	-800 Closed	0 $0
Q1 2019 Apr 04, 2019	BUY	$7.14 - $9.85 $5,712 - $7,880	800 New	800 $7,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.